Keyphrases
Acute Pericarditis
19%
Adjusted Hazard Ratio
12%
All-cause Mortality
21%
Atrial Fibrillation
20%
Cardiac Biomarkers
12%
Cardiac Computed Tomography
12%
Cardiac Intensive Care Unit
14%
Cardiac Magnetic Resonance Imaging (cMRI)
18%
Cardiac Sarcoidosis
16%
Cardiogenic Shock
19%
Cardiovascular Outcomes
13%
Clinical Outcomes
16%
Computed Tomography
12%
Confidence Interval
24%
Constrictive Pericarditis
27%
Coronary Artery Disease
24%
Corticosteroids
14%
COVID-19
34%
Critical Care Cardiology
12%
Echocardiography
22%
Hazard Ratio
18%
High Risk
12%
Hypertrophic Obstructive Cardiomyopathy
23%
Infective Endocarditis
31%
Inflammation
22%
Interleukin-1β
25%
Ischemia
19%
Left Ventricular Function
16%
Mavacamten
26%
Meta-analysis
12%
Multimodal Imaging
32%
Myocardial Perfusion Imaging
20%
Pericardial
27%
Pericardial Disease
27%
Pericardial Effusion
14%
Pericarditis
52%
Pericarditis Recurrence
15%
Placebo
17%
Positron Emission Tomography
21%
Recurrent Pericarditis
70%
Revascularization
17%
Rilonacept
40%
Risk Factors
16%
Risk Stratification
33%
Septal Reduction Therapy
21%
Severe Aortic Stenosis
15%
Stress Testing
14%
Transcatheter Aortic Valve Replacement
32%
Trial Network
12%
Tricuspid Regurgitation
18%
Medicine and Dentistry
Acute Pericarditis
12%
All Cause Mortality
14%
Aortic Stenosis
13%
Assisted Circulation
11%
Atrial Fibrillation
21%
Biological Marker
16%
Cardiac Computed Tomography
11%
Cardiac Magnetic Resonance Imaging
25%
Cardiac Sarcoidosis
19%
Cardiogenic Shock
19%
Cardiology
16%
Cardiovascular Disease
11%
Cardiovascular System
28%
Computer Assisted Tomography
15%
Constrictive Pericarditis
28%
Coronary Artery Disease
32%
Coronary Care Unit
17%
COVID-19
35%
Diseases
25%
Echocardiography
26%
Endocarditis
13%
Fluorodeoxyglucose F 18
13%
Hazard Ratio
31%
Hemodynamic
13%
Hypertrophic Obstructive Cardiomyopathy
17%
Infective Endocarditis
29%
Intensive Care
13%
Interleukin 1
20%
Ischemia
19%
Mavacamten
19%
Meta-Analysis
12%
Mitral Insufficiency
13%
Multimodality Imaging
30%
Myocardial Infarction
12%
Myocardial Perfusion Imaging
26%
Percutaneous Aortic Valve Replacement
31%
Pericardial Disorder
25%
Pericardial Fluid
16%
Pericarditis
100%
Placebo
16%
Polyethylene Terephthalate
11%
Positron Emission Tomography
25%
Positron Emission Tomography-Computed Tomography
14%
Recurrent Disease
26%
Revascularization
16%
Rilonacept
31%
Risk Stratification
33%
Transcatheter Aortic Valve Replacement
11%
Tricuspid Insufficiency
18%
Tricuspid Valve
11%